Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy, Safety and Cost-effectiveness of a Biomarker-based Predictive Model for Persistent Remission in Rheumatoid Arthritis Patients Undergoing Biological Therapy Optimization

NCT07678112 is registered in ClinicalTrials.gov with Francisco J. Blanco as lead sponsor.

NCT NCT07678112
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07678112 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy, Safety and Cost-effectiveness of a Biomarker-based Predictive Model for Persistent Remission in Rheumatoid Arthritis Patients Undergoing Biological Therapy Optimization
Lead sponsor
Francisco J. Blanco
Phase
Not applicable
Overall status
Recruiting
Start date
August 28, 2025
Completion date
August 31, 2027
Enrollment
184 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis (ra)